4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline
CAS: 610798-31-7
Ref. 3D-FE146411
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline
Sinónimos:
- Icotinib
- Bpi 2009H
- Icotinib int. N-1
- N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine
- [1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-
Descrição:
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline is a topoisomerase inhibitor that has been shown to inhibit the proliferation of cancer cells in vitro and in vivo. It inhibits the activity of kinases by binding to active sites on these proteins and blocking the transfer of phosphate groups from ATP to other proteins. This drug also has an effect on hyperproliferative diseases such as lung cancer. 4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline may cause minimal toxicity, but it is not yet clear if it is a suitable replacement for pemetrexed or squamous cell carcinoma treatments.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
